MENU
AUTL
AS OF
Nov 13 closing price
Price
$1.28
Change
-$0.08 (-5.88%)
Capitalization
339.33M
116 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
AUTL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Autolus Therapeutics (AUTL) Earnings Date & Reports

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

AUTL is expected to report earnings to fall 32.93% to -20 cents per share on March 10

Autolus Therapeutics AUTL Stock Earnings Reports
Q4'25
Est.
$-0.20
Q3'25
Missed
by $0.08
Q2'25
Beat
by $0.05
Q1'25
Est.
$-0.26
Q4'24
Beat
by $0.12
The last earnings report on November 12 showed earnings per share of -30 cents, missing the estimate of -21 cents. With 3.14M shares outstanding, the current market capitalization sits at 339.33M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AUTL
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AUTL showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for AUTL
A.I. Advisor
published General Information

General Information

a developer of cancer treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
191 Wood Lane
Phone
+44 2038296230
Employees
471
Web
https://www.autolus.com